Our corporate headquarters are located at 500 Rutherford Avenue Third Floor, Charlestown, MA 02129, USA.
Telephone: +1 617 337 4680
We were originally founded in March 2013.
Solid Biosciences was incorporated in Delaware and converted to a corporation in connection with our initial public offering in January 2018.
Solid Biosciences’ Initial Public Offering occurred on January 25, 2018 at a price of $16.00 per share.
Our fiscal year ends December 31st.
Our common stock is listed on the Nasdaq Global Select Market under the symbol “SLDB”, and our CUSIP number is 83422E 105.
Communications regarding transfer requirements, lost certificates and change of address should be directed to:
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
(800) 962-4284
The auditor for Solid Biosciences is PricewaterhouseCoopers, LLP located in Boston, Massachusetts.
The legal counsel for Solid Biosciences is Wilmer Cutler Pickering Hale and Dorr LLP located in Boston, Massachusetts.
To find out more about Solid Biosciences visit our webpage at www.solidbio.com
Solid Biosciences’ press release archive can be viewed under the “News & Events” section of the “Investor Relations” page and financial reports are available under the Financials section located at our website www.solidbio.com
Solid Biosciences’ SEC Filings can be found on www.sec.gov and are also available under the “Financials” section of the “Investor Relations” page located at our website www.solidbio.com
For a list of the Executive Management team and Board of Directors please visit the “About Us” tab of our website.
For investor inquiries please contact:
Senior Director of Investor Relations & Corporate Communications
investors@solidbio.com